Production and certification of an enzyme reference material for creatine kinase isoenzyme 2 (CRM 608). 1998

F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
Departament de Bioquímica i de Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain.

We describe the preparation of a lyophilized material containing purified human creatine kinase 2 (CK-MB), and the certification of its catalytic concentration. The material can be used to verify the comparability of results from different laboratories, for intra-laboratory quality control, or for calibration of the creatine kinase 2 catalytic concentration measurements. The enzyme was purified from human heart by ethanol precipitation and chromatography successively on DEAE-Sephacel and Blue-Sepharose. The purified enzyme had a specific activity of 998.4 U/mg and was > 99% pure on polyacrylamide gel electrophoresis. The material was examined for several possible contaminating enzymes, which were found to be absent. The purified creatine kinase 2 had two subunits (B and M) with molecular masses of 43,650 and 41,700 g/mol, respectively, and an isoelectric point at pH 5.8. The material was prepared by diluting the purified creatine kinase 2 in a matrix containing 25 mmol/L PIPES buffer, pH 7.2, 2 mmol/L ADP, 5 mmol/L 2-mercaptoethanol, 154 mmol/L sodium chloride and 50 g/L human serum albumin, dispensing it into vials and freeze-drying. The batch was shown to be homogeneous. The loss of enzyme activity on storage at -20 degrees C is predicted to be less than 0.18% per annum on the basis of accelerated degradation studies. The catalytic concentration of creatine kinase in samples of the reconstituted material is certified to be 67.2+/-1.8 U/L (1.12+/-0.03 microkat/L) when measured, at 30 degrees C, by the Recommended Method of the International Federation of Clinical Chemistry.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D002852 Chromatography, Ion Exchange Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. Chromatography, Ion-Exchange,Ion-Exchange Chromatography,Chromatographies, Ion Exchange,Chromatographies, Ion-Exchange,Ion Exchange Chromatographies,Ion Exchange Chromatography,Ion-Exchange Chromatographies
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004795 Enzyme Stability The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat. Enzyme Stabilities,Stabilities, Enzyme,Stability, Enzyme
D005612 Freeze Drying Method of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products. Lyophilization,Drying, Freeze,Dryings, Freeze,Freeze Dryings,Lyophilizations

Related Publications

F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
September 2001, Clinical chemistry and laboratory medicine,
F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
November 1987, Clinical chemistry,
F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
July 1996, Clinica chimica acta; international journal of clinical chemistry,
F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
April 1991, Clinical biochemistry,
F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
November 1987, Clinical chemistry,
F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
April 2001, Clinica chimica acta; international journal of clinical chemistry,
F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
September 2007, Analytical and bioanalytical chemistry,
F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
September 1993, Clinical chemistry,
F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
January 1996, Annales de biologie clinique,
F J Gella, and E Frey, and F Ceriotti, and A Galán, and A G Hadjivassiliou, and M Hørder, and K Lorentz, and D W Moss, and F Schiele, and F Canalias
May 2010, Analytical and bioanalytical chemistry,
Copied contents to your clipboard!